Hydrazine hydrate (1:1) → HCID 178433742, compound

HRID 1530021Notes

Reaction equation

HRID 1530021 reaction equation
[C:1]([C:5]1[N:6]=[C:7]([C:13]2[C:14]([CH3:22])=[N:15][N:16]3[CH:21]=[CH:20][CH:19]=[CH:18][C:17]=23)[S:8][C:9]=1[C:10]([NH2:12])=O)([CH3:4])([CH3:3])[CH3:2].COC(OC)[N:26]([CH3:28])C.O.[NH2:32]N>C(O)(=O)C>[C:1]([C:5]1[N:6]=[C:7]([C:13]2[C:14]([CH3:22])=[N:15][N:16]3[CH:21]=[CH:20][CH:19]=[CH:18][C:17]=23)[S:8][C:9]=1[C:10]1[NH:26][CH:28]=[N:32][N:12]=1)([CH3:4])([CH3:3])[CH3:2]

Participants

5

Procedure

Using 4-tert-butyl-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)-1,3-thiazole-5-carboxamide (230 mg, 0.73 mmol), N,N-dimethylformamide dimethyl acetal (25 mL), acetic acid (25 mL) and hydrazine monohydrate (0.5 mL) as starting materials and in the same manner as in Example 13(vi), the title compound (210 mg, 85%) was obtained as a brown solid.

Sources & evidence

ORD record
ord-74c67e6bea944c7c96731d2d78420a76
Source dataset
uspto-grants-2015_07
Patent number
US09090601B2

Reaction notes

Loading…